RxDoctor Payments Data

David Zacks, MD

Ophthalmology · Ann Arbor, MINPI 1821006529

Payments from drug & device makers

What this record shows

This record is dominated by grants: $175,000 of the $177,160 with a category attached, or 98.8%. Alcon Research LLC accounts for 98.8% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $175,000, more than ten times the $683 reported in 2019. Among ophthalmology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$177,160in general payments, 2019–2025

Across 5 payments — averaging $35,432 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon Research LLC$175K
  • Alcon$2K
  • Eyepoint US, Inc.$76

What the payments were for

  • Grants$175,00099%
  • Travel & lodging$1,6501%
  • Food & beverage$5100%

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alcon Research LLC1$175,000
Alcon3$2,085
Eyepoint US, Inc.1$76

How this compares

$177,160 in reported general payments places this provider in the 95th percentile of 674 ophthalmology providers in Michigan.

See all ophthalmology providers in Michigan

Medicare billing

Part B allowed, 2024
$101,685
Medicare patients
280
Services billed
1,374

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate25$1,185
Ketorolac Tromethamine32$1,124
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat17$338
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha25$299

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →